2-240870670-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP2PP3

The NM_000030.3(AGXT):​c.385G>C​(p.Asp129His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,555,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D129N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

AGXT
NM_000030.3 missense

Scores

4
7
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 2.30

Publications

2 publications found
Variant links:
Genes affected
AGXT (HGNC:341): (alanine--glyoxylate aminotransferase) This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008]
AGXT Gene-Disease associations (from GenCC):
  • alanine glyoxylate aminotransferase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • primary hyperoxaluria type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 130 curated pathogenic missense variants (we use a threshold of 10). The gene has 12 curated benign missense variants. Gene score misZ: -0.26789 (below the threshold of 3.09). Trascript score misZ: -0.48778 (below the threshold of 3.09). GenCC associations: The gene is linked to alanine glyoxylate aminotransferase deficiency, primary hyperoxaluria type 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.788

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000030.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGXT
NM_000030.3
MANE Select
c.385G>Cp.Asp129His
missense
Exon 3 of 11NP_000021.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGXT
ENST00000307503.4
TSL:1 MANE Select
c.385G>Cp.Asp129His
missense
Exon 3 of 11ENSP00000302620.3
AGXT
ENST00000472436.1
TSL:2
n.405G>C
non_coding_transcript_exon
Exon 3 of 5
ENSG00000297735
ENST00000750632.1
n.-201C>G
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152102
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000796
AC:
13
AN:
163230
AF XY:
0.0000928
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000639
Gnomad NFE exome
AF:
0.000187
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000117
AC:
164
AN:
1403444
Hom.:
0
Cov.:
31
AF XY:
0.000103
AC XY:
71
AN XY:
692620
show subpopulations
African (AFR)
AF:
0.0000312
AC:
1
AN:
32040
American (AMR)
AF:
0.00
AC:
0
AN:
36268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25212
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36426
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79580
European-Finnish (FIN)
AF:
0.0000823
AC:
4
AN:
48618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5672
European-Non Finnish (NFE)
AF:
0.000142
AC:
154
AN:
1081440
Other (OTH)
AF:
0.0000859
AC:
5
AN:
58188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152102
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41430
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000958
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.0000720
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 01, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: AGXT c.385G>C (p.Asp129His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-05 in 163230 control chromosomes (gnomAD). This frequency is not higher than the estimated maximum expected for a pathogenic variant in AGXT causing Primary Hyperoxaluria Type 1 (0.0024), allowing no conclusion about variant significance. The variant, c.385G>C, has been reported in the literature to be found in at least one individual affected with Primary Hyperoxaluria Type 1, however no second variant was specified and no phenotype details were provided (Williams_2009); the variant was noted to be found on the major allele. At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated wild-type activity and stability in a yeast growth assay, and normal expression and localization in COS-7 cells, however the variant was expressed on the minor allele (i.e. in cis with the polymorphic variant c.32C>T /P11L, which is less stable and has less activity than the major allele), and authors noted that (though unlikely) it cannot be excluded that this variant could show an effect in the context of the major allele (Lage_2014). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly benign.

not provided Uncertain:1
Sep 24, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid with histidine at codon 129 of the AGXT protein (p.Asp129His). The aspartic acid residue is weakly conserved and there is a moderate physicochemical difference between aspartic acid and histidine. This variant is present in population databases (rs180177212, ExAC 0.01%). This variant has been observed in individual(s) with clinical features of primary hyperoxaluria, type 1 (PMID: 19479957). ClinVar contains an entry for this variant (Variation ID: 204034). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AGXT protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Primary hyperoxaluria, type I Uncertain:1
Oct 27, 2023
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PMID: 24718375 reported normal stability and activity in vitro. ACMG: PM2 PP3 BS3

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Pathogenic
0.29
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
0.16
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.79
D
MetaSVM
Uncertain
0.28
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
2.3
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.7
N
REVEL
Pathogenic
0.69
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.039
D
Polyphen
0.65
P
Vest4
0.71
MVP
0.92
MPC
0.037
ClinPred
0.17
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.27
gMVP
0.78
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180177212; hg19: chr2-241810087; API